2026 ESMO LBA | INNOVENT ANNOUNCES INTERNATIONAL PHASE 3 STUDY OF ARCOTATUG TAVATECAN (CLDN18.2-ADC) IN GASTRIC CANCER MET DUAL PRIMARY ENDPOINTS OF PFS AND OS

Reuters · 3d ago

Please log in to view news